photo walkheader_zpsd5bunpmi.png

Category Archives: Medical Research

Engineered Nano-delivery of Gemcitabine for Pancreatic Cancer (in Mice)

Normally, we do not address pre-clinical studies for pancreatic cancer (ductal adenocarcinoma of the pancreas) in the Pancreatica Blog as so many of these fail when finally subjected to human testing. But sometimes there are such studies that are so intriguing that they cannot be easily ignored. And this particular research study of nanotherapy for […]

Results in on Double Punch Vaccine: Why the FDA Granted Orphan Status to CRS-207 + GVAX in Pancreatic Cancer

A quick note related to an earlier Pancreatica blog posting from October 24, 2013. At the 2014 Gastrointestinal Cancers Symposium in San Francisco (January 16-18) as hosted by the American Society of Clinical Oncology (ASCO), the results of an interesting vaccine study for pancreatic cancer (ductal adenocarcinoma of the pancreas) were released. By way of background […]

MiRNA Panels for the Diagnosis of Pancreatic Cancer ?

A majority of cases of pancreatic cancer (ductal adenocarcinoma of the pancreas) are diagnosed in advanced stage. The main reason is that early stage disease tends to have no symptoms, or vague symptoms.  And there is no good screening test for early pancreatic cancer, or a simple diagnostic indicator.  The two biomarkers most often used with […]

Page 14 of 25« First...1213141516...20...Last »
Facebook
Facebook